Clinical Trial Update: Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using agomelatine to treat depression in people with schizophrenia, with the study status showing completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED